Member Info for TorquayFan

The award is well deserved - fantastic.
GBP 2 million is a mighty whack and for the 'Consortium', I wonder what the total is? If by any chance, early progress is solid or better, I wonder if more funding might appear. GLA

Burble if I may add my thanks for your contributions here. Massively helpful.

Respectfully you underplay this aspect - "With electroporation, you are limited to a hospital with that system deployed." I'm remembering some years ago, the availability of Trigrid machines and the costs, possibly limiting the number of test centres that were viable. However, thanks greatly to Ichor for helping Scancell ignite the science. Maybe we can move on now.

With a flood of CI trials in recent years, for the Patients, the idea of an electric thump here and there, from a miniscule BioTech was not greatly attractive. The alternative methods of dosing will be infinitely preferable. Thanks again.

Ruck I very much agree with you about the comment from Empty. The problem was, after years of anticipating the 'D' problem', someone wanted to deny the obvious existence of it, but a few of us were interested in the maths of it. That's all.

For myself, the recent raising was brilliant and as for the 'D', I'd take more if it means the momentum picks up like this. I'm not picking at Empty, just making the point, it wasn't 'carping'. There we are . . .

Thanks Burble for the review of Prof. Lindy's address (and WTP for the tweet). Moving on . .

Re. the infernal link, this was Bermuda's comment on ADVFN, "Think this is the DNA moditope patent - EPO had previously issued an intention to grant but Scancell have now filed the translations and paid the fee and grant of the patent to be published in the EPO journal on 23rd September."

Here's the entry :-
21.08.2020 (Expected) grant published on 23.09.2020 [2020/39]
18.08.2020 New entry: Receipt of the translation of the claim(s)
18.08.2020 New entry: Payment of fee for grant
18.08.2020 New entry: Payment of fee for publishing/printing
14.08.2020 New entry: Renewal fee paid

Scancell splashing some of the new cash ! All in all, a good day at the office.

Sorry that's a bollard and a home improvement site ! So it's back to ADVFN to view that link !

This worked elsewhere . . . http://hTTps://register.epo.org/application?number=EP17194251&lng=en&tab=event

hTTps://register.epo.org/application?number=EP17194251&lng=en&tab=event

"Investing in companies with COVID-19 pipeline candidates, both treatments and vaccines, has been a winner since March but there is a near-certainty of rough seas next month and beyond when companies release results from ongoing studies and new large-scale trials. Aimed at quick approval, the FDA has set a relatively low bar for vaccine efficacy, 50% compared to placebo . . "

https://seekingalpha.com/news/3606751-investors-in-covidminus-19-stocks-face-turmoil-in-coming-weeks-on-vaccine-data-readouts?

Or . . . https://podcasts.apple.com/gb/podcast/ep1-the-uk-vaccine-taskforce-portfolio-strategy/id1527299221? or Https://podcasts.apple.com/gb/podcast/ep1-the-uk-vaccine-taskforce-portfolio-strategy/id1527299221? or hTTps://podcasts.apple.com/gb/podcast/ep1-the-uk-vaccine-taskforce-portfolio-strategy/id1527299221?

To highlight . . . "it may be the back end of NEXT year before there is a vaccine that is effective enough" - (Patrick Vallance).

"This podcast is worth a listen if you haven't already - first in series on the Covid19 vaccine hunt progress. 20 minutes of Patrick Vallance and Kate Bingham explaining what they are up to and their approach and expectations. Vallance especially interesting in twice flagging the role of TCells and suggesting that it may be the back end of next year before there is a vaccine that is effective enough. I also learned that Kate Bingham reports direct to Boris Johnson...."

hTTps://podcasts.apple.com/gb/podcast/ep1-the-uk-vaccine-taskforce-portfolio-strategy/id1527299221?i=1000487808208

". . . . the companies made the switch after "B2" showed similar immunogenicity but with fewer side effects" and . . . . "Details from an abstract of a 332-subject study posted yesterday showed an adverse event rate of 50% in participants aged 18-55 who received "B1" and 16.7% in older participants (aged 65-85). By comparison, the rates of adverse events for "B2" were 16.7% and 0%, respectively."

Not quite done and dusted . . . . . . .

https://seekingalpha.com/news/3607514-pfizer-biontech-pivot-to-new-covidminus-19-vaccine-candidate-better-safety-profile?

Chester - as for the 'deaf ears', well you tried. However the problem is clearly on both 'sides'. Knowlesi does enjoy playing 'devils advocate', but he is regularly targeted unpleasantly, with smart alec comments in provocation.

As I remember, this conflict emanated years ago from K flagging the coming need for funding long before others wanted to think about it. C7 helpfully withdrew form the fray a while ago but some persist. That's all.

GF thanks for the polite reply.
Knowlesi, I note that 'fact', was a 'likely' fact, so fair enough IMO.
ATB.

Chester I have to agree with K 23.05. Whilst Knowlesi does enjoy playing 'contra advocate', he is routinely targeted unpleasantly, with the 'B' word and smart alec comments in provocation. Your appeal is worthy enough but should IMO be put more widely.

GF123 - I have always doubted your doubters, but recent posts have a style very close to another poster featuring here.

WTP 20.12 - "Great post @RW, hits the nail on the head". No actually - 'hits HIS (RW's) nail on the head'. Also I noticed you were reprimanded about posting on 'politics' last Saturday - IMO that's OK at the weekend which can occasionally pass with hardly a post at all. I was sorry to see you later defer, and whilst not a Member of the 'Islington sect', whatever that is, I'll be peeking at those links later for fun - (moving house atm). ATB

Some excellent posts over on ADVFN yesterday - including . .

"Scientists are growing increasingly confident about the human immune response to SARS-CoV-2 after studies showed antibodies provide “real-world” protection against the virus and cellular immunity may be long-lasting, even in mild cases. "A study of a Covid-19 outbreak on a Seattle fishing boat involving more than 100 sailers has all but proven that antibodies provide protection against re-infection. Meanwhile, an encouraging body of evidence has found that T and B cells remain in the blood even once antibodies fade. “This is exactly what you would hope for,” Marion Pepper, an immunologist at the University of Washington and an author on one of the new studies, told The New York Times. “All the pieces are there to have a totally protective immune response.” " https://www.telegraph.co.uk/global-health/science-and-disease/optimism-covid-19-immunity-climbs-studies-show-antibodies-protect/

Chester I agree completely with your 22.11 about Inan and all the others who contribute to the pith of the matter. Well said.

However, outside the science, Inan makes obvious mistakes and I support those who stick to their guns unremittingly in saying so, (politely), whilst I prefer to avoid the 'quicksand' myself. Somewhere in my mind there's an old analogy about being very very good when good and very very bad when bad which may be relevant.

Nom 23.19 makes 2 seperate points but I didn't see either as aimed at you particularly.

Ruck 21.42 post rec.

BTW Inan - congratulations on reaching the million. Nice one. ATB

We spend years discussing and hoping for non-dilutive funding but when we get dilutive funding, it's OK to know - it's a ratio pure and simple, it has importance in what it measures but that's it. Now I feel duty bound to wrap this up - we may have finally got this right ! Despite flak. The significance of 1 million shareholding is .0215% at 465m total shares issued, .0159% at 629m and .0138% at 726m. I make that 'D' of 30.7% atm and 35.8% if CLN's are converted. That's it and all about it. Oh E. & O.E. ATB

"everyone has there own ideas of what dilution ="

NO Inan - 'everyone' except you, knows what 'D' is !
But YOU have your own ideas.

"any fool can add up the number of shares .......... before and after".
Then DO IT Inan. I'm done on this.

Bunsie 'D' is a relevant point of fact which could have been quickly put to bed without the toys flying around. Inan whines now about getting the flack but it's he's the one that has been in denial, endlessly. I've only posted a few times on this myself. Nothing wrong with your optimism about this great raise. Lets hope BoD will bring some IP to some commercial fruition. ATB